DreamCIS INC.
Contract research organization providing clinical trial, post-marketing surveillance, and site management services to pharma and medtech clients.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 2000 and listed on KOSDAQ in 2020, the company is a contract research organization (CRO). It provides clinical trials (Phase 1-3), post-marketing surveillance (PMS), non-interventional studies (NIS), regulatory consulting, and site management organization (SMO) services to pharmaceutical companies, medical device developers, and research institutions. In 2015 a Chinese CRO acquired an equity stake in the company, after which it pursued business expansion through investment.
Products & technology
- Clinical trial CRO servicesOutsourced clinical trial management for pharma, medtech, and research clients (Phase 1-3)
- Post-marketing surveillance (PMS/rPMS) servicesPost-marketing surveillance services for pharmaceuticals
- Non-interventional study (NIS) supportSupport for observational and non-interventional studies
- Regulatory affairs consultingRegulatory, reimbursement, and clinical support across Korea, US, Europe, Japan, China
- Site Management Organization (SMO) servicesAdministrative and operational support for clinical trial sites (subject recruitment, document/data management, IRB support)
Clinical trials
data.go.kr15 MFDS clinical trial authorisations · 2017–2026 (Phase 3 4 · Phase 2 4 · Phase 1 2 · Phase 1/2 2 · Phase 2a 1)
- Phase 1NS-3422026-08-21
3 trial sites
- Phase 3BGM0504주사제2.5밀리그램,5밀리그램,10밀리그램,15밀리그램2026-07-29
1 trial site
- Phase 2aDB-1303주2024-08-29
6 trial sites
- Phase 3Teclistamab (JNJ-64007957)2022-10-07
6 trial sites
- Phase 2LAE0012022-03-17
5 trial sites
- Phase 1bSIR1-3652022-01-05
14 trial sites
- Phase 3AN20252021-04-01
9 trial sites
- Phase 3Rimegepant (BHV-3000)2020-06-29
26 trial sites
- Phase 1/2AZD42052019-05-13
2 trial sites
- Phase 1MT-5199 캡슐2019-04-05
1 trial site
- Phase 2/3AZD37592018-08-03
9 trial sites
- Phase 2ATG-0082018-06-22
4 trial sites
Show 3 more
- Phase 2AZD37592018-04-26
- Phase 2TJ 3012017-07-05
4 trial sites
- Phase 1/2PLX33972017-02-06
3 trial sites
Companies in the same categoryHealthcare Infrastructure
Supplies red ginseng, probiotics, and other health functional foods to 300+ clients via OEM/ODM.
Founded in 2014 and listed on KOSDAQ in 2024, Cellromax Science is a health functional food company built on a nationwide pharmacy network.
Founded and listed on KOSDAQ in 2014, KolmarBNH develops health functional food and cosmetics materials and provides ODM/OEM manufacturing.
CJ CheilJedang, founded and KOSPI-listed in 2007, operates food, BIO, and logistics businesses as a CJ Group intermediate holding company.
Founded in 1992 and listed on KOSPI in 2006, COSMAX BTI is the COSMAX Group holding company overseeing health food and cosmetics affiliates.
KOSDAQ-listed microbiome healthcare company using the PMAS gut-microbiome simulation platform and the PeachBiome028 probiotic strain.
Founded in 2000 and listed on KOSDAQ in 2018, Icure Pharmaceutical develops TDDS drug patches and cosmetics OEM/ODM.
Carelabs, founded in 2012 and KOSDAQ-listed in 2018, operates mobile healthcare and beauty care platforms.
Founded in 1998 and listed on KOSDAQ in 2021, S&D is a functional food ingredient company.
Founded in 1991 and listed on KOSDAQ in 2002, CosLeaguer Global distributes botulinum toxin and fillers and manufactures cosmetics.
Develops water-solubilized curcumin complexes for enhanced bioavailability using its WIN-T technology.
Founded and listed on KOSDAQ in 2014, GL Pharm Tech is an improved-new-drug pharmaceutical R&D company.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-14
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition